Underreported Risk of Lisinopril-Induced Angioedema in a Veteran Population

CONCLUSION AND RELEVANCE: When estimating the effect of underreporting, the risk of LIA increases to approximately 1.6% or 1 in 63 patients. Because this ADE may affect more patients than previously understood, providers may wish to take LIA into consideration when prescribing lisinopril.PMID:34282637 | DOI:10.1177/10600280211032404
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Source Type: research